Imiquimod (also known as R-837 and S-26308) is an imidazoquinoline immune response
modifier and is available in the US and several other countries for the treatment of external …

Imiquimod, an immunomodulator with no direct in vitro antiviral activity, has in vivo anti-
herpesvirus activity by inducing interferon and enhancing other only partially defined …

Imiquimod, an imidazoquinoline amine, is an immune response modifier recently approved
for the topical treatment of external genital and perianal warts. Although the majority of …

Imiquimod is a topically active immunomodulatory agent that is formulated as a 5% cream
for application by the patient. It is the first agent of its class, the immune response modifiers …

The imidazoquinoline, imiquimod, is a low molecular weight, synthetic immune response
modifier that is used for the treatment of external genital and perianal warts. It is formulated …

The effect of resiquimod (R-848), an immune-response modifier that is similar to imiquimod,
on recurrent herpes simplex virus (HSV) was evaluated using the guinea pig model of …

Imiquimod, an immunomodulator which upregulates cell-mediated immune responses, was
evaluated as an adjuvant for immunotherapy of recurrent genital herpes simplex virus (HSV) …

Imiquimod (S-26308, R-837)(1-(2-methylpropyl)-1H-imidazo [4, 5-c] quinolin-4 amine), an
immune response modifier, demonstrates potent antiviral and antitumor activity in animal …

The adjuvant effects of imiquimod for a herpes simplex virus (HSV) vaccine were evaluated.
Guinea pigs were immunized with 35 µg oflectin-purified HSV-2 glycoproteins 14 and 35 …

Augmenting the host's natural immune response to viruses by the administration of
exogenous cytokines such as interferon-α (IFN-α) is a strategy increasingly employed in …